Journal of Commercial Biotechnology

Leading thinking on biotechnology business management

Journal of Commercial Biotechnology

The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.



Vol 20, No 2 (2014)

Open Access Open Access  Restricted Access Subscription or Fee Access

Table of Contents

Editorial

Building biotechnology in India – Drugs are not the answer PDF
Yali Friedman

Articles

Fostering technology transfer in industrial biotechnology by academic spin-offs PDF
Gunter Festel, Philipp Rittershaus
Pharmaceutical R&D Productivity: The Role of Alliance PDF
Sarah Kruse, Mark Slomiany, Rema Bitar, Sarah Jeffers, Mahmud Hassan
Deciding between biobetter versus biosimilar development options based on net present value calculations PDF
Kerstin Marie Bode-Greuel, Klaus Nickisch
Market Orientation, Alliance Orientation, and Business Performance in the Biotechnology Industry PDF
Grant Alexander Wilson, Jason Perepelkin, David Di Zhang, Marc-Antoine Vachon

From the Classroom

Bioentrepreneurship Education and Training Trends PDF
Arlen Meyers

Intellectual Property Management

Where is the eBay for Intellectual Property? PDF
Matthew B Klusas, Raymond H. Cypess, Seth Rosenfield, Adam Gerstein

From the Boardroom

Biotech IPOs Steam Ahead in 2014 PDF
G. Steven Burrill
Considerations for Start-Up Biotech Company Valuation PDF
Walter Bratic, Justin R Blok, Megan M Gostola
Canadian Venture Capital - Unlocking the Funding Challenge PDF
Christopher H. Jones

Book Reviews

New Books PDF
Yali Friedman


Copyright © thinkBiotech LLC